CXCL12 and leukemia: Preliminary evidence shows that when specifically blocking the SDF-1/CXCR4 signaling axis, the migration and invasion ability of leukemia cells can be effectively attenuated, and the changes of Nrf2 in MSCs did not affect the blocking results of the cells.